Home » Topics » Disease categories and therapies » Hematologic

Hematologic
RSS

Anticoagulant for treating blood clots approved in Canada

Sep. 20, 1996

R&D in blood coauglation at Daiichi

Sep. 13, 1996

Review on gpIIb/IIIa antagonists for ischemic complications

Sep. 13, 1996

Antiplatelet agents reported by Lilly

Sep. 13, 1996

Promising phase I data reported for oral heparin

Sep. 13, 1996

First human trial for transgenic product

Sep. 13, 1996

Genetics Institute's recombinant factor IX submitted for approval

Sep. 6, 1996

Monoclonal antibody for thrombotic disorders from Teijin

Sep. 6, 1996

Roche and Genentech prepare prodrugs of fibrinogen antagonist

Sep. 6, 1996

Bayer's new cGMP PDE inhibitors

Sep. 6, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 20, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...